109 related articles for article (PubMed ID: 38809573)
1. Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validation.
Li ZH; Zhang MY; Federico M; Civallero M; Manni M; Alonso-Alvarez S; Hou J; Huang HH
Cancer; 2024 May; ():. PubMed ID: 38809573
[TBL] [Abstract][Full Text] [Related]
2. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of the transformation of follicular lymphoma to diffuse large B-cell lymphoma in the rituximab era: A population-based study.
Zheng W; Liu M; Guan L; Wang S
Cancer Med; 2024 Apr; 13(8):e7120. PubMed ID: 38629251
[TBL] [Abstract][Full Text] [Related]
4. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
[TBL] [Abstract][Full Text] [Related]
5. Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.
Fernández-Miranda I; Pedrosa L; González-Rincón J; Espinet B; de la Cruz Vicente F; Climent F; Gómez S; Royuela A; Camacho FI; Martín-Acosta P; Yanguas-Casás N; Domínguez M; Méndez M; Colomo L; Salar A; Horcajo B; Navarro M; García-Cosío M; Piris-Villaespesa M; Llanos M; García JF; Sequero S; Mercadal S; García-Hernández S; Navarro B; Mollejo M; Provencio M; Sánchez-Beato M
Mod Pathol; 2024 May; 37(7):100516. PubMed ID: 38763418
[TBL] [Abstract][Full Text] [Related]
6. PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
Beck Enemark M; Monrad I; Madsen C; Lystlund Lauridsen K; Honoré B; Plesner TL; Hamilton-Dutoit SJ; d'Amore F; Ludvigsen M
Onco Targets Ther; 2021; 14():481-489. PubMed ID: 33500624
[TBL] [Abstract][Full Text] [Related]
7. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Watanabe T; Matsuno Y; Wakabayashi M; Maruyama D; Yamamoto K; Kubota N; Shimada K; Asagoe K; Yamaguchi M; Ando K; Ogura M; Kuroda J; Suehiro Y; Tsukasaki K; Tobinai K; Nagai H
Hematol Oncol; 2024 May; 42(3):e3272. PubMed ID: 38595316
[TBL] [Abstract][Full Text] [Related]
8. Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases.
Maeshima AM; Taniguchi H; Ida H; Hosoba R; Fujino T; Saito Y; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2020 Aug; 102():33-43. PubMed ID: 32540222
[TBL] [Abstract][Full Text] [Related]
9. Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group.
Méndez M; Torrente M; Sánchez-Beato M; González-Rincón J; Royuela A; Gómez-Codina J; de la Cruz-Merino L; Rueda A; Llanos M; Quero C; Rodríguez-Abreu D; Gumá J; Monsalvo S; Sabin P; Provencio M
Hematol Oncol; 2019 Apr; 37(2):143-150. PubMed ID: 30840776
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of Histologic Transformation and Prognosis for Follicular Lymphoma].
Zhao TJ; Xu D; Chai XF; Chen YF; Wang DM; Fu XR; Li ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1069-1076. PubMed ID: 37551479
[TBL] [Abstract][Full Text] [Related]
11. Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.
Alonso-Álvarez S; Manni M; Montoto S; Sarkozy C; Morschhauser F; Wondergem MJ; Guarini A; Magnano L; Alcoceba M; Chamuleau M; Galimberti S; Gomes da Silva M; Holte H; Zucca E; Lockmer S; Aurer I; Marcheselli L; Stepanishyna Y; Caballero Barrigón MD; Salles G; Federico M
Eur J Cancer; 2021 Nov; 157():132-139. PubMed ID: 34508995
[TBL] [Abstract][Full Text] [Related]
12. Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
Muntañola A; Mozas P; Mercadal S; Huguet M; Bobillo S; Bastos-Oreiro M; Jiménez-Ubieto A; Rovira J; Rivero A; Tolosa C; Luizaga L; de Villambrosia SG; Novelli S; Caballero D; Salar A; Alonso-Álvarez S; Magnano L; Gutiérrez NC; Sancho JM; López-Guillermo A;
Br J Haematol; 2023 Feb; 200(3):306-314. PubMed ID: 36261137
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China.
Gao F; Zhang T; Liu X; Qu Z; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Wang X; Zhang H
Front Oncol; 2022; 12():863021. PubMed ID: 36185179
[TBL] [Abstract][Full Text] [Related]
14. Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma.
Qu Z; Zhang T; Gao F; Gong W; Cui Y; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Li L; Wang X; Zhang H
Biomed Res Int; 2022; 2022():4379556. PubMed ID: 35655476
[TBL] [Abstract][Full Text] [Related]
15. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
[TBL] [Abstract][Full Text] [Related]
16. The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Hamouzova M; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
Ann Hematol; 2018 Apr; 97(4):669-678. PubMed ID: 29318369
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors and outcome of histological transformation in follicular lymphoma.
Conconi A; Ponzio C; Lobetti-Bodoni C; Motta M; Rancoita PM; Stathis A; Moccia AA; Mazzucchelli L; Bertoni F; Ghielmini M; Cavalli F; Zucca E
Br J Haematol; 2012 Apr; 157(2):188-96. PubMed ID: 22348437
[TBL] [Abstract][Full Text] [Related]
18. [The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma].
Musilová K; Deván J; Zlámalíková L; Křen L; Móciková H; Procházka V; Mayer J; Trněný M; Janíková A; Mráz M
Klin Onkol; 2017; 30(Supplementum1):163-165. PubMed ID: 28471196
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression.
Montoto S; López-Guillermo A; Altés A; Perea G; Ferrer A; Camós M; Villela L; Bosch F; Esteve J; Cervantes F; Bladé J; Nomdedeu B; Campo E; Sierra J; Montserrat E
Ann Oncol; 2004 Oct; 15(10):1484-9. PubMed ID: 15367408
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Features of Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma].
Zhang XL; Yu WJ; Zhu YN; Yang CM; Xiao F; Mai WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1772-1778. PubMed ID: 36476902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
